aminotransferase (ALT) and aspartate aminotransferase (AST) in serum was associated with lower markers of intestinal permeability in serum even when the BMI was not altered.
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Indeed, in this study improvement of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum was associated with lower markers of intestinal permeability in serum even when the BMI was not altered. Regarding the fat intake and especially fatty acid composition of a diet, the findings are controversial. Lipidomic studies suggest that lipid profile and herein especially phospholipid composition of patients with early and more progressed stages of NAFLD are markedly altered when compared to healthy controls and that this may be related to the genetic background of patients [8, 9] . However, the results of animal studies suggest that hepatic lipid export may also be critical [10] . In a placebo controlled dietary intervention study focusing on improving omega-3 index and omega-6 to omega-3 fatty acid ratio through supplementing a high concentrate omega-3 fatty acid preparation (MF4637) beneficial effects found on liver fat content and transaminase activity of NAFLD patients were similar to those of the placebo group treated with olive oil [11] .Still, omega-3 index and absolute values of red blood cell eicosapentaenoic acid and docosahexaenoic acid were only significantly altered in those patients receiving the omega-3 fatty acid preparation. These data further suggest that altering only omega-3 fatty acid concentration by Regarding the fat intake and especially fatty acid composition of a diet, the findings are controversial. Lipidomic studies suggest that lipid profile and herein especially phospholipid composition of patients with early and more progressed stages of NAFLD are markedly altered when compared to healthy controls and that this may be related to the genetic background of patients [8, 9] . However, the results of animal studies suggest that hepatic lipid export may also be critical [10] . In a placebo controlled dietary intervention study focusing on improving omega-3 index and omega-6 to omega-3 fatty acid ratio through supplementing a high concentrate omega-3 fatty acid preparation (MF4637) beneficial effects found on liver fat content and transaminase activity of NAFLD patients were similar to those of the placebo group treated with olive oil [11] .Still, omega-3 index and absolute values of red blood cell eicosapentaenoic acid and docosahexaenoic acid were only significantly altered in those patients receiving the omega-3 fatty acid preparation. These data further suggest that altering only omega-3 fatty acid concentration by itself may not be sufficient to improve the liver status, superior to what can be achieved by altering fat intake towards an increased intake of vegetable oils. Also, considering the cardiovascular risk of patients with NAFLD, it is noteworthy that a recent trial on supplementation with marine n-3 fatty acids was not effective in reducing the number of major cardiovascular events [12] . Results of mouse studies further support the hypothesis that the source of fat and the content of unsaturated fatty acids in diet may be critical in the development of NAFLD. For instance, it was shown that a high fat diet rich in soybean oil -derived omega-6 fatty acids may trigger disease progression [13] and thus further underlines the necessity to carefully consider recommendations provided to patients with NAFLD regarding fat intake.
Not only the intake and circulating levels of macronutrients are deemed to be critical to the development of NAFLD. Indeed, it has been suggested that abnormal serum levels of vitamins are also frequently encountered in patients even with early stages of the disease. For instance, it has been shown that low levels of folate and vitamin B12 are significantly related to severity of NASH [14] . However, the current study did not examine if this related to changes in the dietary pattern with low intake, malabsorption or an increased metabolism of these vitamins, and no implications for disease progression, or even therapeutic application can be made.
Taken together and as presented in the accompanying special issue on nutrition in NAFLD, dietary patterns markedly impact the development and progression of NAFLD and are worthwhile to be addressed in therapeutic interventions. Changes of dietary pattern taking dietary habits of patients into account rather than reducing the overall caloric intake and increasing physical activity may indeed be an alternative or a favorable therapeutic and preventive approach for patients with NAFLD, as adherence is critical for long-term success.
